Search

everythinglearnresearchcommunity

for

Search:↓

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

A special diet can help manage Feline Atopic Skin Syndrome and reduce medication needs in cats.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Frontal fibrosing alopecia is a complex condition with no definitive treatment.

Disrupting the FGF5 gene in rabbits leads to longer hair by extending the hair growth phase.

Alternating treatment with two drugs could help cells in a rapid aging disease.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Hormonal changes during the reproductive cycle may cause seasonal skin problems in captive female fossas.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Laser treatment may help with hair growth in some people with frontal fibrosing alopecia, but results vary and the exact way it works is unclear.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

The patient has frontal fibrosing alopecia (FFA).

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.